Global analysis of O-GlcNAc glycoproteins in activated human t cells

Journal of Immunology

Volumn 197, Issue 8, 2016, Pages 3086-3098

  Lund, Peder J ^a   Elias, Joshua E ^a   Davis, Mark M ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLGLUCOSAMINIDASE; GLYCOPROTEIN; INTERLEUKIN 2; ISOPROTEIN; N ACETYLGLUCOSAMINE; RNA; SERINE; THREONINE; LYMPHOCYTE ANTIGEN RECEPTOR; N ACETYLGLUCOSAMINYLTRANSFERASE; UDP-N-ACETYLGLUCOSAMINE-PEPTIDE BETA-N-ACETYLGLUCOSAMINYLTRANSFERASE;

ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL SYNAPSE; LYMPHOCYTE PROLIFERATION; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RNA METABOLISM; RNA SYNTHESIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; PROTEOMICS; SIGNAL TRANSDUCTION;

ACETYLGLUCOSAMINE; ANIMALS; CELL LINE; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; LYMPHOCYTE ACTIVATION; MICE; N-ACETYLGLUCOSAMINYLTRANSFERASES; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84991511950     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1502031     Document Type: Article

References (89)

1. Acuto, O., V. Di Bartolo, and F. Michel. 2008. Tailoring T-cell receptor signals by proximal negative feedback mechanisms. Nat. Rev. Immunol. 8: 699-712.
2. Smith-Garvin, J. E., G. A. Koretzky, and M. S. Jordan. 2009. T cell activation. Annu. Rev. Immunol. 27: 591-619.
3. Kabouridis, P. S., A. I. Magee, and S. C. Ley. 1997. S-acylation of LCK protein tyrosine kinase is essential for its signalling function in T lymphocytes. EMBO J. 16: 4983-4998.
4. Avni, O., D. Lee, F. Macian, S. J. Szabo, L. H. Glimcher, and A. Rao. 2002. T(H) cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat. Immunol. 3: 643-651.
5. + T cells. Immunity 18: 535-547.
6. Duan, L., A. L. Reddi, A. Ghosh, M. Dimri, and H. Band. 2004. The Cbl family and other ubiquitin ligases: destructive forces in control of antigen receptor signaling. Immunity 21: 7-17.
7. Mueller, D. L. 2004. E3 ubiquitin ligases as T cell anergy factors. Nat. Immunol. 5: 883-890.
8. Liu, Y. C., J. Penninger, and M. Karin. 2005. Immunity by ubiquitylation: a reversible process of modification. Nat. Rev. Immunol. 5: 941-952.
9. +) T-cell response. Blood 108: 3363-3370.
10. Zhu, J., and W. E. Paul. 2008. CD4 T cells: fates, functions, and faults. Blood 112: 1557-1569.
11. + T cells. Immunity 30: 912-925.
12. + T cells. Immunity 30: 155-167.
13. + T cell differentiation and functionality. J. Immunol. 184: 4631-4636.
14. Muller, M. R., and A. Rao. 2010. NFAT, immunity and cancer: a transcription factor comes of age. Nat. Rev. Immunol. 10: 645-656.
15. Nurieva, R. I., S. Zheng, W. Jin, Y. Chung, Y. Zhang, G. J. Martinez, J. M. Reynolds, S. L. Wang, X. Lin, S. C. Sun, et al. 2010. The E3 ubiquitin ligase GRAIL regulates T cell tolerance and regulatory T cell function by mediating T cell receptor-CD3 degradation. Immunity 32: 670-680.
16. Whiting, C. C., L. L. Su, J. T. Lin, and C. G. Fathman. 2011. GRAIL: a unique mediator of CD4 T-lymphocyte unresponsiveness. FEBS J. 278: 47-58.
17. + T helper cell differentiation. Nat. Rev. Immunol. 11: 239-250.
18. Yount, J. S., M. M. Zhang, and H. C. Hang. 2013. Emerging roles for protein Spalmitoylation in immunity from chemical proteomics. Curr. Opin. Chem. Biol. 17: 27-33.
19. Gray, S. M., S. M. Kaech, and M. M. Staron. 2014. The interface between transcriptional and epigenetic control of effector and memory CD8 T-cell differentiation. Immunol. Rev. 261: 157-168.
20. Hart, G. W., M. P. Housley, and C. Slawson. 2007. Cycling of O-linked beta-Nacetylglucosamine on nucleocytoplasmic proteins. Nature 446: 1017-1022.
21. Zeidan, Q., and G. W. Hart. 2010. The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. J. Cell Sci. 123: 13-22.
22. Hart, G. W., C. Slawson, G. Ramirez-Correa, and O. Lagerlof. 2011. Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu. Rev. Biochem. 80: 825-858.
23. Shafi, R., S. P. Iyer, L. G. Ellies, N. O'Donnell, K. W. Marek, D. Chui, G. W. Hart, and J. D. Marth. 2000. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc. Natl. Acad. Sci. USA 97: 5735-5739.
24. Yang, Y. R., M. Song, H. Lee, Y. Jeon, E. J. Choi, H. J. Jang, H. Y. Moon, H. Y. Byun, E. K. Kim, D. H. Kim, et al. 2012. O-GlcNAcase is essential for embryonic development and maintenance of genomic stability. Aging Cell 11: 439-448.
25. O'Donnell, N., N. E. Zachara, G. W. Hart, and J. D. Marth. 2004. Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability. Mol. Cell. Biol. 24: 1680-1690.
26. Yang, W. H., S. Y. Park, H. W. Nam, D. H. Kim, J. G. Kang, E. S. Kang, Y. S. Kim, H. C. Lee, K. S. Kim, and J. W. Cho. 2008. NFkappaB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions. Proc. Natl. Acad. Sci. USA 105: 17345-17350.
27. Hanover, J. A., M. W. Krause, and D. C. Love. 2010. The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine. Biochim. Biophys. Acta 1800: 80-95.
28. Hanover, J. A., M. W. Krause, and D. C. Love. 2012. Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation. Nat. Rev. Mol. Cell Biol. 13: 312-321.
29. Springhorn, C., T. E. Matsha, R. T. Erasmus, and M. F. Essop. 2012. Exploring leukocyte O-GlcNAcylation as a novel diagnostic tool for the earlier detection of type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 97: 4640-4649.
30. Liu, F., J. Shi, H. Tanimukai, J. Gu, J. Gu, I. Grundke-Iqbal, K. Iqbal, and C. X. Gong. 2009. Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease. Brain 132: 1820-1832.
31. Shi, Y., J. Tomic, F. Wen, S. Shaha, A. Bahlo, R. Harrison, J. W. Dennis, R. Williams, B. J. Gross, S. Walker, et al. 2010. Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia. Leukemia 24: 1588-1598.
32. Whelan, S. A., W. B. Dias, L. Thiruneelakantapillai, M. D. Lane, and G.W. Hart. 2010. Regulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-Linked beta-N-acetylglucosamine in 3T3-L1 adipocytes. J. Biol. Chem. 285: 5204-5211.
33. Yi, W., P. M. Clark, D. E. Mason, M. C. Keenan, C. Hill, W. A. Goddard, III, E. C. Peters, E. M. Driggers, and L. C. Hsieh-Wilson. 2012. Phosphofructokinase 1 glycosylation regulates cell growth and metabolism. Science 337: 975-980.
34. Huang, X., Q. Pan, D. Sun, W. Chen, A. Shen, M. Huang, J. Ding, and M. Geng. 2013. O-GlcNAcylation of cofilin promotes breast cancer cell invasion. J. Biol. Chem. 288: 36418-36425.
35. Itkonen, H. M., S. Minner, I. J. Guldvik, M. J. Sandmann, M. C. Tsourlakis, V. Berge, A. Svindland, T. Schlomm, and I. G. Mills. 2013. O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells. Cancer Res. 73: 5277-5287.
36. Jin, F. Z., C. Yu, D. Z. Zhao, M. J.Wu, and Z. Yang. 2013. A correlation between altered O-GlcNAcylation, migration and with changes in E-cadherin levels in ovarian cancer cells. Exp. Cell Res. 319: 1482-1490.
37. Kearse, K. P., and G. W. Hart. 1991. Lymphocyte activation induces rapid changes in nuclear and cytoplasmic glycoproteins. Proc. Natl. Acad. Sci. USA 88: 1701-1705.
38. Golks, A., T. T. Tran, J. F. Goetschy, and D. Guerini. 2007. Requirement for O-linked N-acetylglucosaminyltransferase in lymphocytes activation. EMBO J. 26: 4368-4379.
39. Ramakrishnan, P., P. M. Clark, D. E. Mason, E. C. Peters, L. C. Hsieh-Wilson, and D. Baltimore. 2013. Activation of the transcriptional function of the NF-kB protein c-Rel by O-GlcNAc glycosylation. Sci. Signal. 6: ra75.
40. Pesavento, J. J., B. A. Garcia, J. A. Streeky, N. L. Kelleher, and C. A. Mizzen. 2007. Mild performic acid oxidation enhances chromatographic and top down mass spectrometric analyses of histones. Mol. Cell. Proteomics 6: 1510-1526.
41. Wells, L., K. Vosseller, R. N. Cole, J. M. Cronshaw, M. J. Matunis, and G. W. Hart. 2002. Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications. Mol. Cell. Proteomics 1: 791-804.
42. Vosseller, K., K. C. Hansen, R. J. Chalkley, J. C. Trinidad, L. Wells, G. W. Hart, and A. L. Burlingame. 2005. Quantitative analysis of both protein expression and serine/threonine post-translational modifications through stable isotope labeling with dithiothreitol. Proteomics 5: 388-398.
43. Rybak, J., S. B. Scheurer, D. Neri, and G. Elia. 2004. Purification of biotinylated proteins on streptavidin resin: A protocol for quantitative elution. Proteomics 4: 2296-2299.
44. Eng, J. K., A. L. McCormack, and J. R. Yates. 1994. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 5: 976-989.
45. Elias, J. E., and S. P. Gygi. 2007. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4: 207-214.
46. Gloster, T. M., W. F. Zandberg, J. E. Heinonen, D. L. Shen, L. Deng, and D. J. Vocadlo. 2011. Hijacking a biosynthetic pathway yields a glycosyltransferase inhibitor within cells. Nat. Chem. Biol. 7: 174-181.
47. Yuzwa, S. A., M. S. Macauley, J. E. Heinonen, X. Shan, R. J. Dennis, Y. He, G. E. Whitworth, K. A. Stubbs, E. J. McEachern, G. J. Davies, and D. J. Vocadlo. 2008. A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. Nat. Chem. Biol. 4: 483-490.
48. Yang, X., P. P. Ongusaha, P. D. Miles, J. C. Havstad, F. Zhang, W. V. So, J. E. Kudlow, R. H. Michell, J. M. Olefsky, S. J. Field, and R. M. Evans. 2008. Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature 451: 964-969.
49. Butkinaree, C., K. Park, and G. W. Hart. 2010. O-linked beta-Nacetylglucosamine (O-GlcNAc): extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress. Biochim. Biophys. Acta 1800: 96-106.
50. Fox, C. J., P. S. Hammerman, and C. B. Thompson. 2005. Fuel feeds function: energy metabolism and the T-cell response. Nat. Rev. Immunol. 5: 844-852.
51. Jacobs, S. R., C. E. Herman, N. J. Maciver, J. A. Wofford, H. L. Wieman, J. J. Hammen, and J. C. Rathmell. 2008. Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J. Immunol. 180: 4476-4486.
52. Maciver, N. J., S. R. Jacobs, H. L. Wieman, J. A. Wofford, J. L. Coloff, and J. C. Rathmell. 2008. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J. Leukoc. Biol. 84: 949-957.
53. Boyce, M., I. S. Carrico, A. S. Ganguli, S. H. Yu, M. J. Hangauer, S. C. Hubbard, J. J. Kohler, and C. R. Bertozzi. 2011. Metabolic cross-talk allows labeling of O-linked beta-N-acetylglucosamine-modified proteins via the Nacetylgalactosamine salvage pathway. Proc. Natl. Acad. Sci. USA 108: 3141-3146.
54. Saxon, E., and C. R. Bertozzi. 2000. Cell surface engineering by a modified Staudinger reaction. Science 287: 2007-2010.
55. Hahne, H., N. Sobotzki, T. Nyberg, D. Helm, V. S. Borodkin, D. M. van Aalten, B. Agnew, and B. Kuster. 2013. Proteome wide purification and identification of O-GlcNAc-modified proteins using click chemistry and mass spectrometry. J. Proteome Res. 12: 927-936.
56. Huang, D. W., B. T. Sherman, and R. A. Lempicki. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4: 44-57.
57. Huang, D. W., B. T. Sherman, and R. A. Lempicki. 2009. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37: 1-13.
58. Myers, S. A., S. Daou, B. Affar, and A. Burlingame. 2013. Electron transfer dissociation (ETD): the mass spectrometric breakthrough essential for O-GlcNAc protein site assignments-a study of the O-GlcNAcylated protein host cell factor C1. Proteomics 13: 982-991.
59. Overath, T., U. Kuckelkorn, P. Henklein, B. Strehl, D. Bonar, A. Kloss, D. Siele, P. M. Kloetzel, and K. Janek. 2012. Mapping of O-GlcNAc sites of 20 S proteasome subunits and Hsp90 by a novel biotin-cystamine tag. Mol. Cell. Proteomics 11: 467-477.
60. Khidekel, N., S. Arndt, N. Lamarre-Vincent, A. Lippert, K. G. Poulin-Kerstien, B. Ramakrishnan, P. K. Qasba, and L. C. Hsieh-Wilson. 2003. A chemoenzymatic approach toward the rapid and sensitive detection of O-GlcNAc posttranslational modifications. J. Am. Chem. Soc. 125: 16162-16163.
61. Slawson, C., T. Lakshmanan, S. Knapp, and G. W. Hart. 2008. A mitotic GlcNAcylation/phosphorylation signaling complex alters the posttranslational state of the cytoskeletal protein vimentin. Mol. Biol. Cell 19: 4130-4140.
62. Rexach, J. E., C. J. Rogers, S. H. Yu, J. Tao, Y. E. Sun, and L. C. Hsieh-Wilson. 2010. Quantification of O-glycosylation stoichiometry and dynamics using resolvable mass tags. Nat. Chem. Biol. 6: 645-651.
63. Ranuncolo, S. M., S. Ghosh, J. A. Hanover, G. W. Hart, and B. A. Lewis. 2012. Evidence of the involvement of O-GlcNAc-modified human RNA polymerase II CTD in transcription in vitro and in vivo. J. Biol. Chem. 287: 23549-23561.
64. Hardivillé, S., and G. W. Hart. 2014. Nutrient regulation of signaling, transcription, and cell physiology by O-GlcNAcylation. Cell Metab. 20: 208-213.
65. + T cells is accelerated by TCR stimulation and coordinated by ERK-MAPK. Immunity 19: 535-548.
66. Caldwell, S. A., S. R. Jackson, K. S. Shahriari, T. P. Lynch, G. Sethi, S. Walker, K. Vosseller, and M. J. Reginato. 2010. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene 29: 2831-2842.
67. Lynch, T. P., C. M. Ferrer, S. R. Jackson, K. S. Shahriari, K. Vosseller, and M. J. Reginato. 2012. Critical role of O-linked b-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis. J. Biol. Chem. 287: 11070-11081.
68. Facundo, H. T., R. E. Brainard, L. J. Watson, G. A. Ngoh, T. Hamid, S. D. Prabhu, and S. P. Jones. 2012. O-GlcNAc signaling is essential for NFATmediated transcriptional reprogramming during cardiomyocyte hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 302: H2122-H2130.
69. Pathak, S., J. Alonso, M. Schimpl, K. Rafie, D. E. Blair, V. S. Borodkin, A. W. Schuttelkopf, O. Albarbarawi, and D. M. van Aalten. 2015. The active site of O-GlcNAc transferase imposes constraints on substrate sequence. Nat. Struct. Mol. Biol. 22: 744-750.
70. Lazarus, M. B., Y. Nam, J. Jiang, P. Sliz, and S. Walker. 2011. Structure of human O-GlcNAc transferase and its complex with a peptide substrate. Nature 469: 564-567.
71. Costello, P. S., M. Gallagher, and D. A. Cantrell. 2002. Sustained and dynamic inositol lipid metabolism inside and outside the immunological synapse. Nat. Immunol. 3: 1082-1089.
72. Harriague, J., and G. Bismuth. 2002. Imaging antigen-induced PI3K activation in T cells. Nat. Immunol. 3: 1090-1096.
73. Kreppel, L. K., and G. W. Hart. 1999. Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats. J. Biol. Chem. 274: 32015-32022.
74. Lazarus, B. D., D. C. Love, and J. A. Hanover. 2006. Recombinant O-GlcNAc transferase isoforms: identification of O-GlcNAcase, yes tyrosine kinase, and tau as isoform-specific substrates. Glycobiology 16: 415-421.
75. Wang, R., C. P. Dillon, L. Z. Shi, S. Milasta, R. Carter, D. Finkelstein, L. L. McCormick, P. Fitzgerald, H. Chi, J. Munger, and D. R. Green. 2011. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35: 871-882.
76. Alfaro, J. F., C. X. Gong, M. E. Monroe, J. T. Aldrich, T. R. Clauss, S. O. Purvine, Z. Wang, D. G. Camp, II, J. Shabanowitz, P. Stanley, et al. 2012. Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets. Proc. Natl. Acad. Sci. USA 109: 7280-7285.
77. Trinidad, J. C., D. T. Barkan, B. F. Gulledge, A. Thalhammer, A. Sali, R. Schoepfer, and A. L. Burlingame. 2012. Global identification and characterization of both O-GlcNAcylation and phosphorylation at the murine synapse. Mol. Cell. Proteomics 11: 215-229.
78. Woo, C. M., A. T. Iavarone, D. R. Spiciarich, K. K. Palaniappan, and C. R. Bertozzi. 2015. Isotope-targeted glycoproteomics (IsoTaG): a massindependent platform for intact N-and O-glycopeptide discovery and analysis. Nat. Methods 12: 561-567.
79. Capotosti, F., S. Guernier, F. Lammers, P. Waridel, Y. Cai, J. Jin, J. W. Conaway, R. C. Conaway, and W. Herr. 2011. O-GlcNAc transferase catalyzes site-specific proteolysis of HCF-1. Cell 144: 376-388.
80. Lazarus, M. B., J. Jiang, V. Kapuria, T. Bhuiyan, J. Janetzko, W. F. Zandberg, D. J. Vocadlo, W. Herr, and S. Walker. 2013. HCF-1 is cleaved in the active site of O-GlcNAc transferase. Science 342: 1235-1239.
81. Bordeleau, M. E., R. Aucagne, J. Chagraoui, S. Girard, N. Mayotte, E. Bonneil, P. Thibault, C. Pabst, A. Bergeron, F. Barabé, et al. 2014. UBAP2L is a novel BMI1-interacting protein essential for hematopoietic stem cell activity. Blood 124: 2362-2369.
82. Li, D., and Y. Huang. 2014. Knockdown of ubiquitin associated protein 2-like inhibits the growth and migration of prostate cancer cells. Oncol. Rep. 32: 1578-1584.
83. Mayya, V., D. H. Lundgren, S. I. Hwang, K. Rezaul, L. Wu, J. K. Eng, V. Rodionov, and D. K. Han. 2009. Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci. Signal. 2: ra46.
84. Holt, G. D., C. M. Snow, A. Senior, R. S. Haltiwanger, L. Gerace, and G. W. Hart. 1987. Nuclear pore complex glycoproteins contain cytoplasmically disposed O-linked N-acetylglucosamine. J. Cell Biol. 104: 1157-1164.
85. Zhu, Y., T. W. Liu, Z. Madden, S. A. Yuzwa, K. Murray, S. Cecioni, N. Zachara, and D. J. Vocadlo. 2016. Post-translational O-GlcNAcylation is essential for nuclear pore integrity and maintenance of the pore selectivity filter. J. Mol. Cell Biol. 8: 2-16.
86. Labokha, A. A., S. Gradmann, S. Frey, B. B. Hulsmann, H. Urlaub, M. Baldus, and D. Gö rlich. 2013. Systematic analysis of barrier-forming FG hydrogels from Xenopus nuclear pore complexes. EMBO J. 32: 204-218.
87. Swamy, M., S. Pathak, K. M. Grzes, S. Damerow, L. V. Sinclair, D. M. van Aalten, and D. A. Cantrell. 2016. Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy. Nat. Immunol. 17: 712-720.
88. Arabi, A., S. Wu, K. Ridderstråle, H. Bierhoff, C. Shiue, K. Fatyol, S. Fahlén, P. Hydbring, O. Söderberg, I. Grummt, et al. 2005. c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nat. Cell Biol. 7: 303-310.
89. Grandori, C., N. Gomez-Roman, Z. A. Felton-Edkins, C. Ngouenet, D. A. Galloway, R. N. Eisenman, and R. J. White. 2005. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat. Cell Biol. 7: 311-318.